Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
I-Mab to Participate at the Piper Sandler Healthcare Conference 2024-11-21 20:00
111, Inc. to Participate in Fireside Chat with Water Tower Research on December 6, 2024 2024-11-21 18:00
InxMed FAK Inhibitor Ifebemtinib Received Breakthrough Therapy Designation by China National Medical Products Administration for First-Line Non-Small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation 2024-11-21 15:09
DP Technology and Lepu Biopharma Announce Milestone Collaboration: Leveraging Advanced Computational Methods to Accelerate ADC Drug Innovation 2024-11-21 13:01
Laekna Announces a Clinical Collaboration with Lilly to Develop LAE102, a Novel Monoclonal Antibody Targeting Activin Receptor Type 2A for The Treatment of Obesity 2024-11-20 22:00
CABIO Deepens Commitment to Global Markets, Aiming to Serve International Clients and Pursue Long-Term International Partnerships 2024-11-20 21:00
2024 Global Healthy Longevity Conference Successfully Held 2024-11-20 19:13
Epigenic Therapeutics to Enter Clinical Development of EPI-003: A First-in-Class Epigenetic Inactivator for the Treatment of Chronic Hepatitis B 2024-11-20 07:20
Ractigen Therapeutics Announces FDA Orphan Drug Designation for RAG-21 for the Treatment of ALS 2024-11-19 21:26
Neurizon's NUZ-001 Reduces Aggregation of Key ALS Disease Target TDP-43 in Preclinical Study 2024-11-19 20:30
SK Biopharmaceuticals Seals 1st Actinium-225-Based Collaborative Research Agreement with Korea Institute of Radiological and Medical Sciences as Steps Toward Becoming Global Radiopharmaceutical Therapy Player 2024-11-19 08:00
C Ray Therapeutics Completes Over $100 Million Series A+ Financing, Jointly Led by SCGC and TaiLong Capital 2024-11-18 22:00
Biosion Announces Exclusive, Global License Agreement with Aclaris Therapeutics on two potential First-in-Class and Best-in-Class Immunology Assets 2024-11-18 21:50
FDA Grants Breakthrough Therapy Designation to Huahui Health's Libevitug (HH-003) for treatment of chronic Hepatitis D virus infection 2024-11-18 18:40
SoniVie Ltd., Appoints Veteran Medtech Executive Raymond W. Cohen as Chairman of its Board of Directors 2024-11-18 08:00
Neurophet Appoints CTO Donghyeon Kim as Co-CEO, Joining Jake Junkil Been in Dual Leadership to Drive Global Growth 2024-11-15 22:00
Acepodia Announces FDA Clearance of Investigational New Drug Application for ACE1831 in IgG4-Related Disease 2024-11-15 20:00
Angel Yeast Turns Automation into Opportunity, Ensuring No Job Losses 2024-11-15 20:00
Harbour BioMed Appoints Dr. Raymond Zheng as Chief Business Officer 2024-11-15 09:55
I-Mab Reports Third Quarter 2024 Results 2024-11-14 20:00
1 2 3 4 5 222